Technical Analysis for INO - Inovio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 20.86 -2.75% -0.59
INO closed up 8.72 percent on Thursday, July 2, 2020, on 1.17 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
119 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical INO trend table...

Date Alert Name Type % Chg
1,2,3 Pullback Bullish Bullish Swing Setup -2.75%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -2.75%
Calm After Storm Range Contraction -2.75%
NR7 Range Contraction -2.75%
Multiple of Ten Bullish Other -2.75%
Inside Day Range Contraction -2.75%
Wide Bands Range Expansion -2.75%
1,2,3 Pullback Bullish Bullish Swing Setup 5.73%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.73%
Multiple of Ten Bearish Other 5.73%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases. The company's DNA-based SynCon technology enables the design of vaccines capable of providing cross-protection against new, unmatched strains of pathogens, such as influenza. Its electroporation DNA delivery technology uses controlled electrical pulses to enhance cellular DNA vaccine uptake. The company's clinical programs include human papillomavirus/cervical cancer (therapeutic), avian influenza (preventive), prostate cancer (therapeutic), leukemia (therapeutic), hepatitis C virus, hepatitis B virus, human immunodeficiency virus, and malaria vaccines. It is also advancing preclinical research for a seasonal/pandemic influenza vaccine, as well as other products. Inovio Pharmaceuticals, Inc. has collaboration and license agreements with VGX International, Merck, and ChronTech. The company was formerly known as Inovio Biomedical Corporation and changed its name to Inovio Pharmaceuticals, Inc. in May 2010. Inovio Pharmaceuticals, Inc. was founded in 1983 and is headquartered in Blue Bell, Pennsylvania.
Medicine Medical Specialties Infectious Diseases Cancers Prostate Cancer Coronavirus Influenza Vaccination Leukemia Vaccines Virus Virology Influenza Vaccine Malaria Seasonal/Pandemic Influenza Universal Flu Vaccine

Is INO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 33.79
52 Week Low 1.915
Average Volume 44,781,412
200-Day Moving Average 6.92
50-Day Moving Average 15.18
20-Day Moving Average 18.38
10-Day Moving Average 23.61
Average True Range 3.63
ADX 34.73
+DI 28.72
-DI 18.01
Chandelier Exit (Long, 3 ATRs ) 22.90
Chandelier Exit (Short, 3 ATRs ) 22.02
Upper Bollinger Band 31.87
Lower Bollinger Band 4.88
Percent B (%b) 0.61
BandWidth 146.83
MACD Line 3.28
MACD Signal Line 2.87
MACD Histogram 0.4167
Fundamentals Value
Market Cap 1.94 Billion
Num Shares 90.2 Million
EPS -1.07
Price-to-Earnings (P/E) Ratio -20.05
Price-to-Sales 9.78
Price-to-Book 3.53
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 25.32
Resistance 3 (R3) 25.23 23.86 24.68
Resistance 2 (R2) 23.86 22.87 23.90 24.46
Resistance 1 (R1) 22.65 22.26 23.26 22.74 24.24
Pivot Point 21.28 21.28 21.58 21.32 21.28
Support 1 (S1) 20.07 20.29 20.68 20.16 18.66
Support 2 (S2) 18.70 19.68 18.74 18.44
Support 3 (S3) 17.49 18.70 18.23
Support 4 (S4) 17.58